Daniela S. Rosa

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.

Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.

Journal: Vaccine
Published: June 23, 2026

Sleep continuity and stress physiology are associated with non-inflammatory variation in lymphocyte counts.

Sleep continuity and stress physiology are associated with non-inflammatory variation in lymphocyte counts.

Journal: Sleep medicine
Published: February 19, 2026

An innovative nasal nanovaccine against SARS-CoV-2 induces systemic and upper airway immunity controlling viral replication.

An innovative nasal nanovaccine against SARS-CoV-2 induces systemic and upper airway immunity controlling viral replication.

Journal: NPJ vaccines
Published: July 10, 2025

Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine.

Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine.

Journal: Frontiers in immunology
Published: April 12, 2025

Corrigendum: Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.

Corrigendum: Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.

Journal: Frontiers in immunology
Published: March 22, 2025

Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants.

Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants.

Journal: Virology
Published: March 20, 2025

Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variants.

Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variants.

Journal: Clinical immunology (Orlando, Fla.)
Published: January 03, 2025

Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis.

Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis.

Journal: Frontiers in immunology
Published: December 06, 2024

Genetic overlap and immunological pathways in asthma-obstructive sleep apnea coexistence.

Genetic overlap and immunological pathways in asthma-obstructive sleep apnea coexistence.

Journal: Sleep & breathing = Schlaf & Atmung
Published: April 15, 2024

COVID-19: A Challenge to the Safety of Assisted Reproduction.

COVID-19: A Challenge to the Safety of Assisted Reproduction.

Journal: Sleep medicine clinics
Published: March 19, 2024

Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS-CoV-2 neutralization.

Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS-CoV-2 neutralization.

Journal: Immunity, inflammation and disease
Published: March 11, 2024

Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.

Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.

Journal: Frontiers in immunology
Published: March 06, 2024
Showing 1-12 of 64

Last Updated: 09/26/2026